Overview
Roy Molina is a Hematologist and an Oncologist practicing medicine in Des Moines, Iowa.
Dr. Molina is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Lung Cancer, Pleuropulmonary Blastoma, Bone Marrow Aspiration, and Ureteroscopy.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- HMO
- PPO
Locations
411 Laurel St, Des Moines, IA 50314
Office
Steven Elg is an Oncologist practicing medicine in Des Moines, Iowa. Dr. Elg is highly rated in 25 conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Endometrial Stromal Sarcoma, Malignant Mixed Mullerian Tumor, Ureteroscopy, and Bladder Reconstruction.
Mary Greeley Medical Center
Joseph Merchant is a Hematologist practicing medicine in Ames, Iowa. Dr. Merchant is highly rated in 103 conditions, according to our data. His clinical expertise encompasses Lung Adenocarcinoma, Small Cell Lung Cancer (SCLC), Lung Cancer, Bone Marrow Aspiration, and Endoscopy.
Broadlawns Medical Center
Bradley Lair is an Oncologist practicing medicine in Des Moines, Iowa. Dr. Lair is highly rated in 49 conditions, according to our data. His clinical expertise encompasses Chronic Myelogenous Leukemia (CML), Philadelphia-Negative Chronic Myeloid Leukemia, Hemochromatosis, and Pleuropulmonary Blastoma.
Frequently Asked Questions about Dr. Roy Molina
How do I make an appointment with Dr. Roy Molina?
You can book an appointment with Dr. Roy Molina by calling their office at 515-247-3970. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Roy Molina a top-rated expert for Multiple Myeloma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Roy Molina is classified as an Advanced expert for Multiple Myeloma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Roy Molina specialize in?
While Dr. Roy Molina is a Hematology, they have specific expertise in Multiple Myeloma, Lung Cancer, and Pleuropulmonary Blastoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Roy Molina accept my insurance?
Dr. Roy Molina accepts most major insurance plans, including Humana and Oscar. We recommend calling the office directly at 515-247-3970 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Childhood Iron Deficiency AnemiaDr. Molina isAdvanced. Learn about Childhood Iron Deficiency Anemia.
- Lung CancerDr. Molina isAdvanced. Learn about Lung Cancer.
- Multiple MyelomaDr. Molina isAdvanced. Learn about Multiple Myeloma.
- Paget Disease of the BreastDr. Molina isAdvanced. Learn about Paget Disease of the Breast.
- Pleuropulmonary BlastomaDr. Molina isAdvanced. Learn about Pleuropulmonary Blastoma.
- Small Lymphocytic Lymphoma (SLL)Dr. Molina isAdvanced. Learn about Small Lymphocytic Lymphoma (SLL).
- Experienced
- Acute Mountain SicknessDr. Molina isExperienced. Learn about Acute Mountain Sickness.
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Molina isExperienced. Learn about Acute Myeloid Leukemia (AML).
- AgranulocytosisDr. Molina isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung CancerDr. Molina isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.